BeStock  
Stocks › Biotechnology › IRON

Disc Medicine IRON

US equityMarket cap rank #2340Biotechnology
$75.14 −$0.97 (-1.27%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $75.14 0.00%
Open$75.20
Prev close$76.11
Day range$74.54 – $77.01
Volume561.6K
Market cap$3.42B
P/E (TTM)–
Dividend yield–

IRON Stock News

Headlines matching Disc Medicine or the IRON ticker, most recent first.

  • Liuzhou Iron & Steel Co., Ltd. (601003): A leading steel producer in the Guangxi region, with equity production capacity poised for further expansion. PositiveEverbright Securities · 30 Sep 2026 · Direct mention
  • UBS Initiates CHAMPION IRON LTD(CIAFF.US) With Buy Rating, Announces Target Price $2.89Market news · 29 Sep 2026 · Direct mention
  • Maanshan Iron & Steel Co., Ltd. (600808.SH): Appointed Chen Guorong as Deputy General Manager and Chief Financial OfficerGelonghui Finance · 29 Sep 2026 · Direct mention
  • Maanshan Iron & Steel Company Limited (600808.SH): Jiang Yuxiang Elected as Chairman of the BoardGelonghui Finance · 29 Sep 2026 · Direct mention
  • Maanshan Iron & Steel Co., Ltd. (600808.SH): Appoints Fu Ming as General ManagerGelonghui Finance · 29 Sep 2026 · Direct mention
  • Baoshan Iron & Steel Co., Ltd. (600019): Profitability Remains Leading; High Dividend Yield Expected to PersistCathay Haitong Securities · 24 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Disc Medicine(IRON.US) With Buy Rating, Maintains Target Price $120Market news · 22 Sep 2026 · Direct mention
  • Rothschild & Co Redburn Initiates Iron Mountain(IRM.US) With Buy Rating, Announces Target Price $132Market news · 21 Sep 2026 · Direct mention
  • Truist Financial Maintains Disc Medicine(IRON.US) With Buy RatingMarket news · 21 Sep 2026 · Direct mention
  • Stifel Maintains Iron Mountain(IRM.US) With Buy Rating, Maintains Target Price $140Market news · 18 Sep 2026 · Direct mention
  • Wells Fargo Maintains Disc Medicine(IRON.US) With Buy Rating, Raises Target Price to $86 PositiveMarket news · 16 Sep 2026 · Direct mention
  • BMO Capital Maintains Disc Medicine(IRON.US) With Buy Rating, Maintains Target Price $100Market news · 11 Sep 2026 · Direct mention
  • LifeSci Capital Maintains Disc Medicine(IRON.US) With Buy Rating, Maintains Target Price $100Market news · 10 Sep 2026 · Direct mention
  • Guggenheim Initiates Disc Medicine(IRON.US) With Buy Rating, Announces Target Price $132Market news · 9 Nov 2026 · Direct mention
  • A Quick Look at Today's Ratings for Iron Mountain(IRM.US), With a Forecast Between $124 to $147Market news · 7 Nov 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on IRON.

Sign in to join the discussion.

Scroll to Top